Cellular receptor binding and entry of human papillomavirus

Virology Journal

Volumn 7, Issue , 2010, Pages

  Letian, Tan ^a   Tianyu, Zhang ^b  

^a EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; CLATHRIN; HEPARAN SULFATE; PROTEOHEPARAN SULFATE; SYNDECAN 1; SYNDECAN 4; VIRUS RECEPTOR;

ENDOCYTOSIS; NONHUMAN; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VERRUCA VULGARIS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS MORPHOLOGY; WART VIRUS; BIOLOGICAL MODEL; HUMAN; PAPILLOMA VIRUS; PHYSIOLOGY; VIRUS ENTRY;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

HUMANS; MODELS, BIOLOGICAL; PAPILLOMAVIRIDAE; RECEPTORS, VIRUS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 76949103745     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-2     Document Type: Review

References (45)

1. Interaction of papillomaviruses with the cell surface. RB Roden R Kirnbauer AB Jenson DR Lowy JT Schiller, J Virol 1994 68 7260 7266 7933109
2. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. M Evander IH Frazer E Payne YM Qi K Hengst NA McMillan, J Virol 1997 71 2449 2456 9032382
3. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. NA Patterson JL Smith MA Ozbun, J Virol 2005 79 6838 6847 10.1128/JVI.79.11.6838-6847.2005 15890923
4. Replication and assembly of humanpapillomaviruses. MJ Conway C Meyers, J Dent Res 2009 88 307 317 10.1177/0022034509333446 19407149
5. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. HK Wang AA Duffy TR Broker LT Chow, Genes Dev 2009 23 181 194 10.1101/gad.1735109 19131434
6. A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions. LT Chow AA Duffy HK Wang TR Broker, Cell Cycle 2009 8 1319 1323 19342877
7. Papillomavirus capsid binding and uptake by cells from different tissues and species. M Muller L Gissmann RJ Cristiano XY Sun IH Frazer AB Jenson A Alonso H Zentgraf J Zhou, J Virol 1995 69 948 954 7815562
8. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. C Volpers F Unckell P Schirmacher RE Streeck M Sapp, J Virol 1995 69 3258 3264 7745672
9. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. YM Qi SW Peng K Hengst M Evander DS Park J Zhou IH Frazer, Virology 1996 216 35 45 10.1006/viro.1996.0032 8615005
10. Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. NA McMillan E Payne IH Frazer M Evander, Virology 1999 261 271 279 10.1006/viro.1999.9825 10497112
11. alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. CS Yoon KD Kim SN Park SW Cheong, Biochem Biophys Res Commun 2001 283 668 673 10.1006/bbrc.2001.4838 11341777
12. Proteolytic processing of endogenous and recombinant beta 4 integrin subunit. FG Giancotti MA Stepp S Suzuki E Engvall E Ruoslahti, J Cell Biol 1992 118 951 959 10.1083/jcb.118.4.951 1500432
13. A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. S Kajiji RN Tamura V Quaranta, EMBO J 1989 8 673 680 2542022
14. Surface relocation of alpha 6 beta 4 integrins and assembly of hemidesmosomes in an in vitro model of wound healing. MA Kurpakus V Quaranta JC Jones, J Cell Biol 1991 115 1737 1750 10.1083/jcb.115.6.1737 1757471
15. Cells can use their transferrin receptors for locomotion. MS Bretscher, EMBO J 1992 11 383 389 1537325
16. Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. A Sonnenberg J Calafat H Janssen H Daams LM van der Raaij-Helmer R Falcioni SJ Kennel JD Aplin J Baker M Loizidou D Garrod, J Cell Biol 1991 113 907 917 10.1083/jcb.113.4.907 2026654
17. Further evidence that papillomavirus capsids exist in two distinct conformations. HC Selinka T Giroglou T Nowak ND Christensen M Sapp, J Virol 2003 77 12961 12967 10.1128/JVI.77.24.12961-12967.2003 14645552
18. Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. M Knappe S Bodevin HC Selinka D Spillmann RE Streeck XS Chen U Lindahl M Sapp, J Biol Chem 2007 282 27913 27922 10.1074/jbc.M705127200 17640876
19. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. JG Joyce JS Tung CT Przysiecki JC Cook ED Lehman JA Sands KU Jansen PM Keller, J Biol Chem 1999 274 5810 5822 10.1074/jbc.274.9.5810 10026203
20. Human papillomavirus infection requires cell surface heparan sulfate. T Giroglou L Florin F Schafer RE Streeck M Sapp, J Virol 2001 75 1565 1570 10.1128/JVI.75.3.1565-1570.2001 11152531
21. Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. AL Combita A Touze L Bousarghin PY Sizaret N Munoz P Coursaget, FEMS Microbiol Lett 2001 204 183 188 10.1111/j.1574-6968.2001.tb10883.x 11682199
22. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. HC Selinka T Giroglou M Sapp, Virology 2002 299 279 287 10.1006/viro.2001.1493 12202231
23. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. S Shafti-Keramat A Handisurya E Kriehuber G Meneguzzi K Slupetzky R Kirnbauer, J Virol 2003 77 13125 13135 10.1128/JVI.77.24.13125- 13135.2003 14645569
24. Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA. O Rommel J Dillner C Fligge C Bergsdorf X Wang HC Selinka M Sapp, J Med Virol 2005 75 114 121 10.1002/jmv.20245 15543569
25. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. XS Chen RL Garcea I Goldberg G Casini SC Harrison, Mol Cell 2000 5 557 567 10.1016/S1097-2765(00)80449-9 10882140
26. Atomic model of the papillomavirus capsid. Y Modis BL Trus SC Harrison, EMBO J 2002 21 4754 4762 10.1093/emboj/cdf494 12234916
27. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. PM Day CD Thompson CB Buck YY Pang DR Lowy JT Schiller, J Virol 2007 81 8784 8792 10.1128/JVI.00552-07 17553881
28. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1. JJ Carter GC Wipf SF Benki ND Christensen DA Galloway, J Virol 2003 77 11625 11632 10.1128/JVI.77.21.11625- 11632.2003 14557648
29. alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. G Sibbet C Romero-Graillet G Meneguzzi MS Campo, J Gen Virol 2000 81 327 334 10644830
30. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. KM Johnson RC Kines JN Roberts DR Lowy JT Schiller PM Day, J Virol 2009 83 2067 2074 10.1128/JVI.02190-08 19073722
31. Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. D Mudhakir H Harashima, AAPS J 2009 11 65 77 10.1208/s12248-009-9080-9 19194803
32. Dissecting virus entry via endocytosis. SB Sieczkarski GR Whittaker, J Gen Virol 2002 83 1535 1545 12075072
33. Papillomaviruses infect cells via a clathrin-dependent pathway. PM Day DR Lowy JT Schiller, Virology 2003 307 1 11 10.1016/S0042-6822(02)00143-5 12667809
34. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. L Bousarghin A Touze PY Sizaret P Coursaget, J Virol 2003 77 3846 3850 10.1128/JVI.77.6.3846-3850.2003 12610160
35. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. PL Hindmarsh LA Laimins, Virol J 2007 4 19 10.1186/1743-422X-4-19 17324266
36. Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. JL Smith SK Campos MA Ozbun, J Virol 2007 81 9922 9931 Laniosz V, Holthusen KA, Meneses PI: Bovine papillomavirus type 1: from clathrin to caveolin. J Virol 2008, 82 :6288-6298. 10.1128/JVI.00988-07 17626097
37. Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. JL Smith SK Campos A Wandinger-Ness MA Ozbun, J Virol 2008 82 9505 9512 10.1128/JVI.01014-08 18667513
38. Bovine papillomavirus type 1: from clathrin to caveolin. V Laniosz KA Holthusen PI Meneses, J Virol 2008 82 6288 6298 10.1128/JVI.00569-08 18417596
39. HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. CY Abban NA Bradbury PI Meneses, Am J Ther 2008 15 304 311 10.1097/MJT.0b013e3181754134 18645330
40. Clathrin- and caveolin-independent entry of human papillomavirus type 16 - involvement of tetraspanin-enriched microdomains (TEMs). G Spoden K Freitag M Husmann K Boller M Sapp C Lambert L Florin, PLoS One 2008 3 3313 10.1371/journal.pone.0003313 18836553
41. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. ME Hemler, Annu Rev Cell Dev Biol 2003 19 397 422 10.1146/annurev.cellbio.19.111301.153609 14570575
42. Protein-protein interactions in the tetraspanin web. S Levy T Shoham, Physiology (Bethesda) 2005 20 218 224 16024509
43. Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. PM Day DR Lowy JT Schiller, J Virol 2008 82 12565 12568 10.1128/JVI.01631-08 18829767
44. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. RM Richards DR Lowy JT Schiller PM Day, Proc Natl Acad Sci USA 2006 103 1522 1527 10.1073/pnas.0508815103 16432208
45. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. N Kamper PM Day T Nowak HC Selinka L Florin J Bolscher L Hilbig JT Schiller M Sapp, J Virol 2006 80 759 768 10.1128/JVI.80.2.759-768.2006 16378978